Culture
Novartis drug cuts inflammation.
A heart outcomes study is to come A newly acquired Novartis drug cut signs of inflammation. A newly acquired Novartis drug cut signs of inflammation.
Dr. Kai NakamuraChief Science CorrespondentPublished Aug 29, 2026 at 3:37 AM EDT · 1 min read
A heart outcomes study is to come A newly acquired Novartis drug cut signs of inflammation. A newly acquired Novartis drug cut signs of inflammation.
Continue reading
Latest →Corrections, sourcing and article labels are part of the publication record. See our editorial standards.